Sara González

3.6k total citations
43 papers, 2.4k citations indexed

About

Sara González is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Sara González has authored 43 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 17 papers in Cellular and Molecular Neuroscience and 8 papers in Endocrine and Autonomic Systems. Recurrent topics in Sara González's work include Cannabis and Cannabinoid Research (23 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Sara González is often cited by papers focused on Cannabis and Cannabinoid Research (23 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Sara González collaborates with scholars based in Spain, United States and Italy. Sara González's co-authors include Javier Fernández‐Ruíz, J.A. Ramos, Vincenzo Di Marzo, Julián Romero, M. Cebeira, Moisés Garcı́a-Arencibia, Raphael Mechoulam, Filomena Fezza, Tiziana Bisogno and Rosa M. Tolón and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Sara González

41 papers receiving 2.4k citations

Peers

Countries citing papers authored by Sara González

Since Specialization

Citations

This map shows the geographic impact of Sara González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara González more than expected).

Fields of papers citing papers by Sara González

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara González. The network helps show where Sara González may publish in the future.

Co-authorship network of co-authors of Sara González

This figure shows the co-authorship network connecting the top 25 collaborators of Sara González. A scholar is included among the top collaborators of Sara González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara González. Sara González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anesthetic management in critical tracheal stenosis surgery using Tritube® and flow-controlled ventilation: A report of two cases 2025 ·Revista Española de Anestesiología y Reanimación (English Edition) ·(unknown), (unknown), E. Fuente, Sara González, (unknown), (unknown)	0
2	Manejo anestésico en la cirugía de estenosis traqueal crítica con Tritube® y ventilación controlada por flujo: a propósito de 2 casos 2025 ·Revista Española de Anestesiología y Reanimación ·(unknown), (unknown), E. Fuente, Sara González, M. Rueda, (unknown)	0
3	Subjective cognitive decline and cognitive change among diverse middle‐aged and older Hispanic/Latino adults: Results from the Study of Latinos–Investigation of Neurocognitive Aging (SOL‐INCA) 2024 ·Alzheimer s & Dementia ·(unknown), Wassim Tarraf, (unknown), (unknown), Ariana M. Stickel, Alejandra Morlett Paredes, Lourdes R. Guerrero, Krista M. Perreira, Sylvia Wassertheil‐Smoller, Sara González, Christian R. Salazar, Martha L. Daviglus, Linda C. Gallo, Hector M. González	2
4	Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism 2023 ·Thrombosis Research ·(unknown), Carmen Rodríguez, Alfonso Muriel, Sara González, (unknown), (unknown), (unknown), Remedios Otero, Behnood Bikdeli, David Jiménez	8
5	Awareness and utilization of genetic testing among Hispanic and Latino adults living in the US: The Hispanic Community Health Study/Study of Latinos 2022 ·Human Genetics and Genomics Advances ·Kurt D. Christensen, Mengran Zhang, (unknown), Einat Granot‐Hershkovitz, Sarah C. Nelson, Sara González, Maria Argos, Krista M. Perreira, Martha L. Daviglus, Carmen R. Isasi, Jianwen Cai, Gregory A. Talavera, Carrie L. Blout Zawatsky, Robert C. Green, Rosario Isasi, Robert C. Kaplan, Tamar Sofer	4
6	Usefulness of the National Early Warning Score for Risk Stratification of Stable Patients With Acute Symptomatic Pulmonary Embolism 2022 ·Archivos de Bronconeumología ·Carmen Rodríguez, (unknown), (unknown), (unknown), Sara González, (unknown), Ignacio Jara, (unknown), Jorge Moisés, Raquel Morillo, David Jiménez	2
7	Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial 2022 ·Thrombosis Journal ·Carmen Rodríguez, Luis Jara‐Palomares, (unknown), (unknown), Sara González, (unknown), José Luís Lobo, Raquel Morillo, Behnood Bikdeli, David Jiménez	1
8	Actividad antioxidante de antocianinas presentes en cáscara de pitahaya (Hylocereus undatus) 2011 ·Redalyc (Universidad Autónoma del Estado de México) ·(unknown), (unknown), Sara González, (unknown), (unknown)	3
9	Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease 2009 ·Proceedings of the National Academy of Sciences ·Aldrín E. Molero, Şölen Gökhan, Sara González, Jessica L. Feig, (unknown), Mark F. Mehler	86
10	Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease 2006 ·Brain Research ·Sara González, Camila Scorticati, Moisés Garcı́a-Arencibia, Rosario de Miguel, J.A. Ramos, Javier Fernández‐Ruíz	89
11	Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice 2005 ·Brain Research ·Sara González, María A. Mena, Isabel Lastres‐Becker, (unknown), Justo Garcı́a de Yébenes, J.A. Ramos, Javier Fernández‐Ruíz	28
12	Cannabinoid Control of Motor Function at the Basal Ganglia 2005 ·Handbook of experimental pharmacology ·Javier Fernández‐Ruíz, Sara González	55
13	Behavioral and molecular changes elicited by acute administration of SR141716 to Δ9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence 2004 ·Drug and Alcohol Dependence ·Sara González, Javier Fernández‐Ruíz, Vincenzo Di Marzo, Mariluz Hernández, Cristina Arévalo, (unknown), Maria Grazia Cascio, Emilio Ambrosio, J.A. Ramos	54
14	Changes in endocannabinoid contents in reward‐related brain regions of alcohol‐exposed rats, and their possible relevance to alcohol relapse 2004 ·British Journal of Pharmacology ·Sara González, Marta Valenti, Rosario de Miguel, Filomena Fezza, Javier Fernández‐Ruíz, Vincenzo Di Marzo, J.A. Ramos	64
15	Cannabinoid CB₂ receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study 2004 ·Synapse ·Estefanía Núñez, Cristina Benito, M. Ruth Pazos, Antonio Barbáchano, Otto Fajardo, Sara González, Rosa M. Tolón, Julián Romero	269
16	Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine 2002 ·Brain Research ·Sara González, Maria Grazia Cascio, Javier Fernández‐Ruíz, Filomena Fezza, Vincenzo Di Marzo, J.A. Ramos	228
17	Endocannabinoids and basal ganglia functionality 2002 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Javier Fernández‐Ruíz, Isabel Lastres‐Becker, Ana Cabranes, Sara González, J.A. Ramos	50
18	Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels 2002 ·Drug and Alcohol Dependence ·Sara González, Javier Fernández‐Ruíz, (unknown), Daniela Parolaro, José A. Ramos	118
19	The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats 2002 ·Life Sciences ·Tibor Wenger, Ida Gerendai, Filomena Fezza, Sara González, Tiziana Bisogno, Javier Fernández‐Ruíz, Vincenzo Di Marzo	48
20	Decreased Cannabinoid CB1 Receptor mRNA Levels and Immunoreactivity in Pituitary Tumors Induced by Prolonged Exposure to Estrogens 2000 ·Pituitary ·Sara González, (unknown), Fernando Berrendero, J.A. Ramos, Maria Fosca Franzoni, Javier Fernández‐Ruíz	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact